Abstract Number: 1812 • 2014 ACR/ARHP Annual Meeting
Investigation of the Sting/Interferon Pathway Activation in a Novel Vasculopathy and Pulmonary Syndrome
Background/Purpose: We have recently studied a group of patients with a prominent interferon (IFN) signature in the blood, distinct from IL-1 mediated autoinflammatory diseases. Six…Abstract Number: 1811 • 2014 ACR/ARHP Annual Meeting
The Burden of Depression on Healthcare Utilization in a Population-Based Cohort of Patients with Systemic Lupus Erythematosus
Background/Purpose . Systemic lupus erythematosus (SLE) is a chronic disease that disproportionately strikes black women. Depression is a potentially debilitating co-morbidity that affects 15-75% of…Abstract Number: 1810 • 2014 ACR/ARHP Annual Meeting
Improper Use of Antinuclear Antibody (ANA) Test Can Result in Misdiagnosis, Increased Patient Anxiety, and Wasted Health Care Resources
Background/Purpose: Results of serologic tests for autoantibodies, including tests for Antinuclear antibodies (ANAs) and antibodies to specific nuclear antigens such as double-stranded DNA (dsDNA), play…Abstract Number: 1809 • 2014 ACR/ARHP Annual Meeting
Is Team Care Better? a Comparison of Rheumatoid Arthritis Disease Activity Among Patients Cared for in Practices with Nurse Practitioners and Physicians Assistants Versus Rheumatologist Only
Background/Purpose: The Affordable Care Act proposes more widespread use of mid-level providers (MLPs), such as nurse practitioners and physician assistants, but little is known about…Abstract Number: 1808 • 2014 ACR/ARHP Annual Meeting
Role of HLA-B*5801 Genetic Testing and a Safety Programme When Initiating Allopurinol Therapy for Chronic Gout Management: A Cost-Effectiveness Analysis
Background/Purpose To conduct a cost-effectiveness analysis from a health system perspective of various strategies in managing chronic gout to mitigate risk of allopurinol-induced Stevens-Johnson Syndrome…Abstract Number: 1807 • 2014 ACR/ARHP Annual Meeting
Problems with Fee for Service Payments for Academic Rheumatology Practices: A Need for Payment Reform:
Background/Purpose: The current fee-for-service model rewards providers for the volume of services. The model is designed to deliver higher compensation for care of more complex cases. Rheumatologists…Abstract Number: 1805 • 2014 ACR/ARHP Annual Meeting
Prevalence and Associating Factors with Atypical Femoral Fractures: An Asian Single Center Based Case-Control Study
Background/Purpose Although the use of bisphosphonates has been shown to reduce vertebral and proximal femur fracture risk in patients with osteoporosis, current evidence suggests that…Abstract Number: 1826 • 2014 ACR/ARHP Annual Meeting
A Renal Activity Index May Predict Histological Activity in Lupus Nephritis in Children
Background/Purpose Lupus Nephritis (LN) occurs in up to 80% of childhood-onset Systemic Lupus Erythematosus (cSLE) and it has a worse prognosis than adults. The current…Abstract Number: 1825 • 2014 ACR/ARHP Annual Meeting
Cognitive Performance Scores for the Pediatric Automated Neuropsychological Assessment Metrics in Childhood-Onset Systemic Lupus Erythematosus
Background/Purpose: Patients with childhood-onset SLE (cSLE) may experience neuropsychiatric SLE (NPSLE) manifested as neurocognitive dysfunction (NCD). Formal neurocognitive testing (FNCT) is the most accepted method…Abstract Number: 1791 • 2014 ACR/ARHP Annual Meeting
Applicability of the 2006 European League Against Rheumatism (EULAR) Criteria for the Classification of Henoch-Schönlein Purpura. an Analysis Based on 766 Patients with Cutaneous Vasculitis
Background/Purpose The European League Against Rheumatism (EULAR) proposed in 2006 a new classification criteria for Henoch-Schönlein Purpura (HSP). We aimed to establish the applicability of…Abstract Number: 1790 • 2014 ACR/ARHP Annual Meeting
Follow up of an Unselected IgA Vasculitis (Henoch-Schönlein Purpura) Population at Single Rheumatology Center
Background/Purpose In our population IgA vasculitis (IgAV) has an annual incidence rate of 5.1 cases per 105 adults increasing with patients’ age which makes it…Abstract Number: 1789 • 2014 ACR/ARHP Annual Meeting
Are EULAR/Printo/PRES Classification Criteria Appropriate for Classification of IgA Vasculitis in Adults?
Background/Purpose In 2010 EULAR/PRINTO/PRES proposed new classification criteria for pediatric IgA vasculitis (IgAV). In pediatric population these criteria have a higher diagnostic sensitivity than the…Abstract Number: 1788 • 2014 ACR/ARHP Annual Meeting
Association of HLA-B*41 with Henoch-Schönlein Purpura in Spanish Individuals Irrespective of the HLA-DRB1 Status
Background/Purpose: Henoch-Schönlein purpura (HSP), the most common type of primary small-sized blood vessel leukocytoclastic vasculitis, is characterized by infiltration of the small blood vessels with…Abstract Number: 1787 • 2014 ACR/ARHP Annual Meeting
HLA-DRB1*01 Is Associated with Henoch- Schönlein Purpura in the Spanish Population
Background/Purpose: Henoch-Schönlein purpura (HSP) is essentially a childhood disease, being the most common type of vasculitis in children and an infrequent condition in adults. An…Abstract Number: 1786 • 2014 ACR/ARHP Annual Meeting
Vasculitis As Underlying Cause of Death in the United States: 1999 – 2010
Background/Purpose Current data on mortality rates of primary vasculitis, which were tradionally associated with a dreadful prognosis, are limited. Therefore, we aimed to estimate the mortality rates…
ACR Meeting Abstracts